These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 32372107)

  • 1. CHA
    Faganello G; Barbati G; Russo G; Scagnetto A; Mazzone C; Mottolese BD'; Zaccari M; Sinagra G; Lenarda AD; Cioffi G
    Pediatr Cardiol; 2020 Jun; 41(5):1051-1057. PubMed ID: 32372107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictive role of CHA
    Mazzone C; Cioffi G; Carriere C; Barbati G; Faganello G; Russo G; Cherubini A; Sinagra G; Zeriali N; Di Lenarda A
    Eur J Prev Cardiol; 2017 Oct; 24(15):1584-1593. PubMed ID: 28812917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CHA
    Sonaglioni A; Lonati C; Rigamonti E; Viganò M; Nicolosi GL; Proietti M; Lombardo M; Harari S
    Aging Clin Exp Res; 2022 Jul; 34(7):1707-1720. PubMed ID: 35294768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CHA
    Parsons C; Patel SI; Cha S; Shen WK; Desai S; Chamberlain AM; Luis SA; Aguilar MI; Demaerschalk BM; Mookadam F; Shamoun F
    Mayo Clin Proc; 2017 Mar; 92(3):360-369. PubMed ID: 28259228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of the CHA2DS2-VASc Score in Predicting Ischemic Stroke, Thromboembolism, and Death in Patients With Heart Failure With and Without Atrial Fibrillation.
    Melgaard L; Gorst-Rasmussen A; Lane DA; Rasmussen LH; Larsen TB; Lip GY
    JAMA; 2015 Sep; 314(10):1030-8. PubMed ID: 26318604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CHA2DS2-VASc and ATRIA Scores and Clinical Outcomes in Patients with Heart Failure with Preserved Ejection Fraction.
    Zhu W; Wu Y; Zhou Y; Liang W; Xue R; Wu Z; Dong Y; Liu C
    Cardiovasc Drugs Ther; 2020 Dec; 34(6):763-772. PubMed ID: 32583288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Value of the CHADS
    Yang HJ; Wang GJ; Shuai W; Shen CJ; Kong B; Huang H
    J Stroke Cerebrovasc Dis; 2019 Nov; 28(11):104143. PubMed ID: 31477449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of the CHA2DS2-VASc score with left atrial spontaneous echo contrast: a cross-sectional study of patients with rheumatic mitral stenosis in sinus rhythm.
    Belen E; Ozal E; Pusuroglu H
    Heart Vessels; 2016 Sep; 31(9):1537-43. PubMed ID: 26475711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Usefulness of CHA
    Cioffi G; Viapiana O; Orsolini G; Idolazzi L; Fracassi E; Ognibeni F; Dalbeni A; Gatti D; Carletto A; Fassio A; Rossini M; Giollo A
    Int J Rheum Dis; 2020 Jan; 23(1):106-115. PubMed ID: 31854508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The thromboembolism risk of low-risk atrial fibrillation patients with different clinical characteristics].
    Liu XB; Jia ZX; Xia SJ; He L; Lu SX; Guo XY; Li SN; Liu N; Jiang CX; Sang CH; Tang RB; Long DY; Yu RH; Bai R; Wu JH; Du X; Dong JZ; Ma CS
    Zhonghua Xin Xue Guan Bing Za Zhi; 2020 Sep; 48(9):735-739. PubMed ID: 32957755
    [No Abstract]   [Full Text] [Related]  

  • 11. Pre-stroke CHADS2 and CHA2DS2-VASc scores are useful in stratifying three-month outcomes in patients with and without atrial fibrillation.
    Tu HT; Campbell BC; Meretoja A; Churilov L; Lees KR; Donnan GA; Davis SM
    Cerebrovasc Dis; 2013; 36(4):273-80. PubMed ID: 24135809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of risk score (CHADS2 versus CHA2DS2-VASc) on long-term outcomes after atrial fibrillation ablation.
    Jacobs V; May HT; Bair TL; Crandall BG; Cutler M; Day JD; Weiss JP; Osborn JS; Muhlestein JB; Anderson JL; Mallender C; Bunch TJ
    Heart Rhythm; 2015 Apr; 12(4):681-6. PubMed ID: 25546809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early Rhythm Control in Patients With Atrial Fibrillation and High Comorbidity Burden.
    Rillig A; Borof K; Breithardt G; Camm AJ; Crijns HJGM; Goette A; Kuck KH; Metzner A; Vardas P; Vettorazzi E; Wegscheider K; Zapf A; Kirchhof P
    Circulation; 2022 Sep; 146(11):836-847. PubMed ID: 35968706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Performance of the CHA
    Pieralli F; Biondo B; Vannucchi V; Falcone M; Antonielli E; De Marzi G; Casati C; Maddaluni L; Nozzoli C; Olivotto I
    Eur J Intern Med; 2019 Apr; 62():24-28. PubMed ID: 30692019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison between CHADS2 and CHA2DS2-VASc score for risk stratification of ischemic stroke in Japanese patients with non-valvular paroxysmal atrial fibrillation not receiving anticoagulant therapy.
    Komatsu T; Sato Y; Ozawa M; Kunugita F; Yoshizawa R; Morino Y; Nakamura M
    Int Heart J; 2014; 55(2):119-25. PubMed ID: 24632957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictive Value of CHA
    Wang X; Pei C; Bai Y; Dai Q; Deng X; Liu Y; Li Z; You J; Peng J; Lin L; Zou Y
    Angiology; 2019 Oct; 70(9):878-886. PubMed ID: 30317861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CHADS
    Wu JT; Wang SL; Chu YJ; Long DY; Dong JZ; Fan XW; Yang HT; Duan HY; Yan LJ; Qian P
    J Atheroscler Thromb; 2017 Feb; 24(2):176-184. PubMed ID: 27301462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CHA
    Sanchez Fernandez JJ; Ortiz MR; Ballesteros FM; Luque CO; Penas ER; Ortega MD; Rubio DM
    J Neurol; 2020 Oct; 267(10):3061-3068. PubMed ID: 32529579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Meta-analysis of CHADS2 versus CHA2DS2-VASc for predicting stroke and thromboembolism in atrial fibrillation patients independent of anticoagulation.
    Zhu WG; Xiong QM; Hong K
    Tex Heart Inst J; 2015 Feb; 42(1):6-15. PubMed ID: 25873792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risks of Ischemic Stroke/Transient Ischemic Attack Based on CHA
    Li J; Hidru TH; Yang X; Yang Y; Liu F; Lou Z; Guan X; Wu S; Xia Y
    Int Heart J; 2021 Mar; 62(2):312-319. PubMed ID: 33678799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.